PIER CAPITAL, LLC CRISPR Therapeutics AG Transaction History

PIER CAPITAL, LLC portfolio value:

$0
portfolio value

PIER CAPITAL, LLC quarter portfolio value change:

+7.54%
quarter

CRISPR Therapeutics AG 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -7.96K shares -484K $65.35 0
Q2 2022 share Decrease -27.04% -2.95K shares -201K $60.77 7.96K
Q1 2022 share Increase +21.98% 1.96K shares 7K $62.77 10.91K
Q4 2021 share Increase +38.99% 2.50K shares -42K $78.85 8.94K
Q3 2021 share Increase +0.96% 61 shares -312K $111.93 6.43K
Q2 2021 share Increase 0.00% 6.37K shares 1.03M $161.89 6.37K